Statement of the DDB on the change of leadership in the Philippine Drug Enforcement Agency

The Dangerous Drugs Board welcomes the assumption of new PDEA Director General Wilkins Villanueva after Malacañang released his appointment signed last 22 May 2020. Incoming DG Villanueva has been a steadfast partner of DDB even during his early years as career officer of PDEA. DDB has involved him in many of its anti-drug efforts particularly in policy formulation and strategy development aspects which helped craft many of its inter-agency priorities all these years. Recognizing him as the 7th Director-General of PDEA, DDB intends to engage more closely and deepen the collaboration with his leadership noting that he will become an Ex-Officio Member of the Board.

Read more ...

DDB Eases the Use of Prescription Forms for Dangerous Drugs

The Dangerous Drugs Board now allows the use of ordinary prescription for medical preparations containing dangerous drugs.

Read more ...

DDB advocates for the use of electronic prescription for dangerous drugs medication

The Dangerous Drugs Board appeals to doctors, pharmacists, and drug store personnel to consider the use of electronic prescription for medicines included in the list of dangerous drugs as the whole country is under a State of Calamity due to the COVID-19 pandemic.

Read more ...

DDB, SDA Church hold program to update health directors on the Philippine Anti-Illegal Drugs Strategy (PADS) and board regulations

The Dangerous Drugs Board, in collaboration with the Southern Asia-Pacific Division of the Seventh-Day Adventist Church, convenes Luzon-based health directors of the religious group to update them on the Philippine Anti-Illegal Drugs Strategy (PADS) and relevant DDB regulations.

Read more ...

DDB clarifies: CBD is not cannabis per se

The Dangerous Drugs Board would like to clarify that marijuana use remains illegal in the country for both recreational and medical use. The use of Cannabidiol, however, is being considered to be allowed for treatment of certain rare forms of epilepsy like Lennox-Gastaut and Dravet Syndrome.

Read more ...

DDB, DOST-FNRI launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

DDB, DOST-FNRI to launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, will officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

PRRD reappoints Cuy as Chairperson of DDB

Secretary Catalino S. Cuy was given a fresh mandate as the Chairperson of the Dangerous Drugs Board (DDB).

This was confirmed after President Rodrigo Duterte signed his reappointment papers on 21 January 2020. Secretary Cuy was first appointed at the DDB in January 2018 serving the remainder of the term of his predecessor.

Read more ...

DDB’s response to the recommendations of the Vice President on the campaign against illegal drugs

The Dangerous Drugs Board notes the recommendations of Vice President Leni Robredo on the anti-drug campaign. The agency keeps in mind the ultimate goal of establishing drug-free communities as a serious commitment of the Duterte Administration.

Read more ...

(Facility based)
CY 2004

AGE : Mean age of 29 years
SEX : Ratio of male to female 9:1
CIVIL STATUS : Single 53.15%
FAMILY SIZE : Three (3) to four (4) siblings
OCCUPATION : Unemployed 38%
Workers / Employees 29.53%
EDUCATIONAL ATTAINMENT : High School level 28.93%
ECONOMIC STATUS:Average monthly family income P13,553.36
PLACE OF RESIDENCE : Urban (specifically NCR)
DURATION OF DRUG TAKING : More than six (6) years
NATURE OF DRUG – TAKING : Poly drug use
DRUGS OF ABUSE : Methamphetamine Hydrochloride (Shabu)
                                 Cannabis (Marijuana)
                                 Cough/Cold Preparations

*Residential and Out-Patient Facility


       For the year 2004, the reported cases were predominantly male with a ratio of 9:1. Most of them are single (53.15%) while the rest are either married (32.26%); with live-in partners (7.57%), or were separated (5.94%).

       The highest percent distribution of center clients is steady within the age groups 25-29 and 20-24, with 21.50% and 19.70%, respectively. The mean or average age is 29 years old.

(Facility - Based)
CY 2004

                                                   MALE             FEMALE       GRAND TOTAL
NEW ADMISSIONS 4,196 72.51 484 8.36 4,680 80.87
READMISSIONS 840 14.52 47 0.81 887 15.33
OUT - PATIENT 189 3.27 31 0.54 220 3.80
T O T A L 5,225 90.29 562 9.71 5,787 100.00

* Total reported cases from residential and out-patient facilities


The Integrated Central Case Registry and Monitoring System (ICCRMS)

       Year-end submissions for 2004 received from 53 residential and 1 outpatient facilities reporting with the DDB revealed a total of 5,787 cases for the year to include 4,680 (80.87%) new admissions, 887 admissions, relapse and outpatient cases as compared to the figures of 2003. This may be attributable to the high cost of treatment in private rehabilitation centers, which may have served as a deterrent for drug dependents to seek the appropriate intervention.

       The region with the most number of cases of 2004 is the NCR with 51.46%. Regions IV-A (16.81%), III (16.54%), VII (4.94%), and XI (3.75%) follow to complete the first five ranking. The least number of cases come from the ARMM with only .03%.

       As to educational attainment, those who were in the high school level has the highest percent distribution with 28.93% followed closely by those in the college level with 27.91% while 16.76% were clients who have graduated in high school before they sought treatment and rehabilitation.

       With regard to the classification of patients, 38% of the total cases were employed, 29.53% were workers, 8.92% were either businessmen or self-employed, 5.37% were students, and .79% were out-of-school youth prior to their admission for treatment.

       Of the total workers’/employees’ group of 1,709, the unskilled workers (those who are untrained or inexperienced like the bet takers, baggers, barkers, etc.) ranked first with 39.20%. Following closely are the semi-skilled ones (those who require less training and exercise less independent judgment such as the service crews, tailors, drivers, and others who operate machines) with 37.39%. The professionals comprised 17.50% while the skilled workers (those who have been trained or are experts in a particular occupation like the technicians, chefs, etc.) represented 5.91%.

       The average family monthly income of the center clients rose to ₱13,553.36 from the previous year’s ₱12,358.48.

       84.45% of the total cases abused Shabu, Marijuana (31.73%); cough/cold preparations (3.73%); benzodiazephines (3.72%) inhalants (3.28%); Ecstasy (1.43%); Cocaine (1.26%); Nalbuphine Hydrochloride (.81%); opium (.90%); Psilocybin (.19%); Mescaline (.10%); and Datura or “Talampunay” (.07%).

(Facility Based)*

DRUGS USED / ABUSED NEW ADMISSIONS RE-ADMISSIONS OUT-PATIENT GRAND TOTAL % based on the total number of responses (7,703) % based on the total number of admissions (5,787)
1. SHABU (STIMULANT) 3,929 807 151 4,887 63.44 84.45
2. MARIJUANA (CANNABIS) 1,395 289 152 1,836 23.83 31.73
3. COUGH / COLD PREPARATIONS 157 59   216 2.80 3.73
4. BENZODIAZEPINES 138 77   215 2.79 3.72
5. INHALANTS 161 14 15 190 2.47 3.28
6. ECSTASY (STIMULANT) 70 13   83 1.08 1.43
7. COCAINE (STIMULANT) 51 22   73 0.95 1.26
8. OPIUM (MORPHINE / HEROIN) 27 25   52 0.68 0.90
9. NUBAIN (NARCOTIC / ANALGESIC) 25 22   47 0.61 0.81
10. PSILOCYBIN (MAGIC MUSHROOM) 8 3   11 0.14 0.19
11. MESCALINE (HALLUCINOGEN) 5 1   6 0.08 0.10
12. DATURA (TALAMPUNAY) 4     4 0.05 0.07
OTHER DRUGS 62 23   83 1.08 1.43
TOTAL       7,703 100.00  

        Methamphetamine Hydrochloride, commonly known as Shabu, remains as the no. 1 drug of abuse with 4,887 cases (63.43%). Marijuana is in No. 2 with 1,836 cases (23.83%) while in the third position are the cough/cold preparations having 216 cases (2.80%). Benzodiazepines were also commonly used by 215 (2.79%). Inhalants came in at fifth with 190 (2.47%) cases while Ecstasy ranks sixth with 83 (1.08%) cases.

       The routes of administration are that of inhalation or sniffing and oral ingestion.